» Articles » PMID: 35642642

Lipid Balance Must Be Just Right to Prevent Development of Severe Liver Damage

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2022 Jun 1
PMID 35642642
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) is a major health concern that often associates with obesity and diabetes. Fatty liver is usually a benign condition, yet a fraction of individuals progress to severe forms of liver damage, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Elevated sterol regulatory element-binding protein-driven (SREBP-driven) hepatocyte lipid synthesis is associated with NAFLD in humans and mice. In this issue of the JCI, Kawamura, Matsushita, et al. evaluated the role of SREBP-dependent lipid synthesis in the development of NAFLD, NASH, and HCC in the phosphatase and tensin homolog-knockout (PTEN-knockout) NASH model. Deletion of the gene encoding SREBP cleavage-activating protein (SCAP) from the liver resulted in decreased hepatic lipids, as expected. However, SCAP deletion accelerated progression to more severe liver damage, including NASH and HCC. This study provides a note of caution for those pursuing de novo fat biosynthesis as a therapeutic intervention in human NASH.

Citing Articles

SR-A3 suppresses AKT activation to protect against MAFLD by inhibiting XIAP-mediated PTEN degradation.

Lai P, Miao G, Zhao Y, Han Y, Li Y, Liu Y Nat Commun. 2025; 16(1):2430.

PMID: 40069146 PMC: 11897346. DOI: 10.1038/s41467-025-57585-0.


Investigation of Active Components of (Maxim.) Franch in Mitigating Non-Alcoholic Fatty Liver Disease.

Lu Q, La M, Wang Z, Huang J, Zhu J, Zhang D Int J Mol Sci. 2025; 26(1.

PMID: 39795910 PMC: 11719989. DOI: 10.3390/ijms26010050.


The significance of lipid metabolism reprogramming of tumor-associated macrophages in hepatocellular carcinoma.

Xie Q, Zeng Y, Zhang X, Yu F Cancer Immunol Immunother. 2024; 73(9):171.

PMID: 38954021 PMC: 11220057. DOI: 10.1007/s00262-024-03748-9.


Aqueous extract of Artemisia capillaris improves non-alcoholic fatty liver and obesity in mice induced by high-fat diet.

Liang M, Huo M, Guo Y, Zhang Y, Xiao X, Xv J Front Pharmacol. 2022; 13:1084435.

PMID: 36518663 PMC: 9742474. DOI: 10.3389/fphar.2022.1084435.

References
1.
Febbraio M, Reibe S, Shalapour S, Ooi G, Watt M, Karin M . Preclinical Models for Studying NASH-Driven HCC: How Useful Are They?. Cell Metab. 2018; 29(1):18-26. PMC: 6326872. DOI: 10.1016/j.cmet.2018.10.012. View

2.
Moon Y, Liang G, Xie X, Frank-Kamenetsky M, FitzGerald K, Koteliansky V . The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 2012; 15(2):240-6. PMC: 3662050. DOI: 10.1016/j.cmet.2011.12.017. View

3.
Ueno T, Sato W, Horie Y, Komatsu M, Tanida I, Yoshida M . Loss of Pten, a tumor suppressor, causes the strong inhibition of autophagy without affecting LC3 lipidation. Autophagy. 2008; 4(5):692-700. DOI: 10.4161/auto.6085. View

4.
Horton J, Shah N, Warrington J, Anderson N, Park S, Brown M . Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A. 2003; 100(21):12027-32. PMC: 218707. DOI: 10.1073/pnas.1534923100. View

5.
Kawamura S, Matsushita Y, Kurosaki S, Tange M, Fujiwara N, Hayata Y . Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis. J Clin Invest. 2022; 132(11). PMC: 9151706. DOI: 10.1172/JCI151895. View